STOCK TITAN

Zentalis Pharmaceuticals (ZNTL) Total Assets by Year

ZNTL NASDAQ

Zentalis Pharmaceuticals, Inc. closed fiscal year 2025 with $289.0M in total assets, $72.8M in total liabilities and $216.2M in shareholder equity. Total assets fell 32.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Zentalis Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Total Assets $289.0M
Total Liabilities $72.8M
Total Equity $216.2M
YoY -32.9%
5Y CAGR -4.6%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ZNTL Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-QFY2410-KFY2310-KFY2210-QFY2110-KFY20FilingFY19Filing
Total Assets$289.0M-32.9%$430.3M-22.0%$551.7M+2.3%$539.3M+18.7%$454.5M+24.3%$365.6M+317.9%$87.5M
Total Liabilities$72.8M-21.9%$93.2M-18.5%$114.3M+8.6%$105.3M+17.0%$90.0M+179.8%$32.2M-80.8%$167.6M
Total Equity$216.2M-35.9%$337.2M-22.9%$437.3M+0.8%$433.8M+19.2%$364.0M+17.9%$308.6Mn/m-$80.1M

ZNTL Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$270.2M-17.4%$215.3M-38.8%$253.1M-34.1%$289.0M-32.9%$327.3M-27.4%$351.7M-28.5%$384.0M-31.1%$430.3M-22.0%$450.7M-23.1%$491.7M-20.9%$557.5M+13.9%$551.7M+2.3%
Total Liabilities$65.3M-12.2%$71.7M-7.2%$70.4M-20.6%$72.8M-21.9%$74.4M-22.8%$77.2M-29.2%$88.6M-10.2%$93.2M-18.5%$96.3M-7.2%$109.1M+11.1%$98.7M-4.8%$114.3M+8.6%
Total Equity$204.9M-19.0%$143.6M-47.7%$182.7M-38.2%$216.2M-35.9%$252.9M-28.6%$274.5M-28.3%$295.4M-35.6%$337.2M-22.9%$354.3M-26.5%$382.6M-26.9%$458.8M+19.0%$437.3M+0.8%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Zentalis Pharmaceuticals, Inc. financials

Frequently Asked Questions

Zentalis Pharmaceuticals, Inc. closed fiscal year 2025 with $289.0M in total assets, $72.8M in total liabilities and $216.2M in shareholder equity.

Zentalis Pharmaceuticals, Inc. (ZNTL) total assets fell by 32.9% year over year, from $430.3M to $289.0M in fiscal year 2025.

Across the 7 fiscal years this page covers, Zentalis Pharmaceuticals, Inc. (ZNTL) total assets went from $87.5M in fiscal year 2019 to $289.0M in fiscal year 2025.

Zentalis Pharmaceuticals, Inc. (ZNTL) reported $270.2M in total assets in Q3 2026. This represents a decrease of 17.4% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Zentalis Pharmaceuticals, Inc. (ZNTL) reported on that line in every period on record.